C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/62 (2006.01) A61K 39/395 (2006.01) A61K 47/48 (2006.01) A61K 49/00 (2006.01) A61K 51/10 (2006.01) C07K 7/06 (2006.01) C07K 7/08 (2006.01) C07K 14/16 (2006.01) C07K 14/705 (2006.01) C07K 16/28 (2006.01) C07K 16/30 (2006.01) C07K 19/00 (2006.01) C12N 15/12 (2006.01) C12P 21/08 (2006.01) G01N 33/574 (2006.01) G01N 33/577 (2006.01) A61K 38/00 (2006.01) A61K 39/00 (2006.01)
Patent
CA 2149635
2149635 9412631 PCTABS00032 There is marked over-expression of multiple spliced variants of the CD44 gene in tumour compared to counterpart normal tissue. This observation forms the basis of a method of diagnosing neoplasia by analysis of a sample of body tissue or body fluid or waste product. A new exon 6 of 129bp has been located and sequenced. Antibodies specific to the exon have been prepared and are claimed as new compounds suitable for use in the detection of CD44 proteins and for the in vivo imaging and therapy of tumours.
Matsumura Yasuhiro
Tarin David
Isis Innovation Ltd.
Kirby Eades Gale Baker
LandOfFree
Peptide corresponding to cd44 exon 6, antibodies specific... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Peptide corresponding to cd44 exon 6, antibodies specific..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptide corresponding to cd44 exon 6, antibodies specific... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1452070